What Is Cross-Linked Polyvinylpyrrolidone (Crospovidone) Used for in Tablets?

Cross-linked polyvinylpyrrolidone, commonly called crospovidone, is an insoluble pharmaceutical excipient used mainly as a superdisintegrant in tablets. It helps a tablet break apart after contact with liquid, which can support the release and dispersion of its active ingredient. Formulators may add it within the granules, outside the granules, or in both locations, depending on the manufacturing process and the product’s performance goals. The right grade and concentration should be confirmed through formulation trials rather than assumed from the ingredient name alone.

View Details

Key Takeaways

• Crospovidone is used primarily to promote tablet disintegration; it is not the active pharmaceutical ingredient.
• Its porous, cross-linked structure supports liquid uptake and tablet breakup without dissolving like a soluble polymer.
• Formulators can evaluate it through intragranular, extragranular, or combined addition.
• A common development starting range is approximately 2–5% w/w of the tablet formulation, but the suitable level depends on the product and process.
• Buyers should verify the grade, specification, documentation, and supply requirements for their intended market and application.

What Is Crospovidone?

Crospovidone is a cross-linked form of polyvinylpyrrolidone (PVP). The cross-linked structure makes it practically insoluble in water, distinguishing it from soluble PVP grades used for other functions. In a tablet, the material is included as an excipient: a component that supports manufacturing or product performance rather than providing the intended therapeutic effect.

Its main pharmaceutical role is disintegration. When a tablet contacts liquid, crospovidone can help the liquid enter the compact and encourage the tablet to break into smaller particles. The precise contribution depends on factors such as the tablet’s composition, porosity, compression, and manufacturing method, so performance should be assessed in the complete formulation.

What Is Crospovidone Used for in Tablets?

Promoting Tablet Disintegration

The principal use of crospovidone is to help tablets disintegrate after administration or when placed in a test medium. Faster or more reliable breakup can be important when a product is designed to release its ingredients from a conventional immediate-release tablet. However, disintegration is not the same as dissolution: an excipient may help a tablet break apart, but it does not by itself establish how quickly an active ingredient dissolves or becomes available.

Crospovidone’s structure supports liquid uptake through capillary action, often described as wicking, and physical disruption of the tablet as it becomes wetted. Its performance is influenced by the surrounding formulation and processing conditions. Therefore, the excipient should be evaluated with the intended active ingredient, other excipients, and target tablet properties rather than selected on function alone.

Supporting Formulation and Manufacturing Choices

Formulators can add crospovidone at different stages. Intragranular addition places some or all of the excipient within granules, while extragranular addition blends it with the granules before compression. A combined approach may also be evaluated, but the best choice depends on the formulation and process; it should not be treated as a universal rule.

For early development, a formulation team may screen levels such as 1%, 3%, and 5% w/w of the tablet blend. These are proposed trial points, not a guaranteed optimum or a supplier specification. A common starting range in tablet development is approximately 2–5% w/w, but the appropriate amount can vary with the active ingredient, tablet design, and manufacturing conditions.

Where It Is Used

Crospovidone is considered for many conventional tablet formulations where disintegration is a target. It may be evaluated in direct-compression or granulated products, subject to compatibility and process testing. Its inclusion can be relevant to immediate-release tablets, but the final product’s performance must be demonstrated using the manufacturer’s established methods and acceptance criteria.

It may also be considered in orally disintegrating tablet development, where rapid breakup in the mouth is a formulation objective. That application requires attention to the complete sensory and performance profile, including mouthfeel, tablet strength, and moisture management. Crospovidone alone does not guarantee a particular disintegration time or user experience.

For more information, please visit NKY Group.

Material Options and Important Specifications

Commercial crospovidone may be offered in different grades or particle-size profiles. Differences in material properties can affect blending, flow, compaction, and disintegration behavior, so a grade used successfully in one formula should not automatically be considered interchangeable with another. Buyers should request the supplier’s current product specification and evaluate the proposed material in their own process.

Documentation and specifications vary by product and supplier, so buyers should confirm the exact documents available for the selected grade. If a particular pharmacopeial or regulatory expectation applies, state it during the inquiry and verify the supplier’s supporting information. Do not infer compliance from the generic term “crospovidone” alone.

How to Select Crospovidone for a Tablet Project

Match the Grade to the Formulation

Begin by defining the tablet type, process, and performance target. Share whether the product uses direct compression or granulation, how the excipient will be added, and any known constraints related to flow, tablet strength, or moisture sensitivity. This context makes supplier discussions and technical comparisons more useful than requesting a price for an unspecified material.

Evaluate Performance in the Finished Tablet

Compare candidate levels and addition methods using the same active ingredient and manufacturing conditions wherever possible. Assess relevant properties such as disintegration, tablet hardness, friability, and manufacturing behavior according to your development protocol. A change in excipient level can affect more than one attribute, so teams should review the overall balance rather than optimizing a single result in isolation.

Check Compatibility and Change Control

Review the material alongside the other excipients and the active ingredient, and consider whether the manufacturing process could alter performance. Before changing a crospovidone grade or supplier, evaluate the change under your quality and regulatory procedures. The impact of a substitution depends on the product and applicable requirements; a supplier’s general description is not a replacement for product-specific assessment.

How NKY Group Can Support Buyers

At NKY Group, we support B2B inquiries for cross-linked polyvinylpyrrolidone by helping buyers clarify the material and sourcing information needed for evaluation. We can discuss the intended tablet application, requested grade or specification, order quantity, packaging needs, and destination market. Availability of specific grades, documents, and delivery arrangements should be confirmed for each inquiry.

To make an inquiry actionable, include the target application, preferred specification or compendial requirements, estimated quantity, and any documentation needs. If you are still developing the formulation, share the process type and performance objective so that the material discussion can be framed around your evaluation. Final selection and acceptance should remain subject to your technical review and applicable quality procedures.

Conclusion

Cross-linked polyvinylpyrrolidone, or crospovidone, is used in tablets primarily as a superdisintegrant to support liquid uptake and tablet breakup. It can be incorporated within granules, outside them, or through a combined approach, with the appropriate method and concentration determined by formulation trials. For a practical next step, define your tablet process and performance goals, request the relevant specification and documentation, and compare candidate grades in the finished formulation. NKY Group welcomes B2B inquiries with your application, target requirements, and sourcing needs.

If you are looking for more details, kindly visit cross linked polyvinylpyrrolidone.